2017

LONDON and CARLSBAD, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted […]

by

The state where I live has legalized medical marijuana (MMJ) and it’s getting ready to open state-licensed marijuana dispensaries. So, I’ve been thinking about using MMJ to treat some of my MS symptoms. How can MMJ help MS patients? A 2012 study by researchers at the University of Plymouth in the U.K. reported improvement in […]

by

LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced it has submitted its Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Epidiolex® (cannabidiol or […]

by

London und Carlsbad, Kalifornien (ots/PRNewswire) – GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” oder “das Unternehmen”), ein biopharmazeutisches Unternehmen, das sich auf die Erforschung, Entwicklung und Vermarktung von neuartigen Therapeutika auf Basis seiner proprietren Plattform von Cannabinoid-Produkten konzentriert, hat heute bekanntgegeben, dass es bei der Europischen Arzneimittel-Agentur (EMA) einen Antrag auf Marktzulassung (MAA) fr Epidiolex® (Cannabidiol […]

by

This morning, GW Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for Epidolex (cannabidiol) as an adjunctive treatment for seizures in Lennox-Gastaut syndrome (LGS) and Dravet syndrome, a pair of rare, severe childhood-onset epilepsy disorders. The NDA was submitted at the end of October. The […]

by

LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced it has submitted its Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Epidiolex® (cannabidiol or […]

by

The Top CBD Cannabis Studies of 2017 The past year was important for proponents of medical cannabis. Those seeking to remove cannabis’ Schedule I status are now armed with even more evidence for its medicinal and wellness benefits from a combination of human and rodent studies. From benefits in epilepsy, autism, and beyond, here are […]

by

Gainers Pareteum Corp (NYSE: TEUM) shares jumped 120.87 percent to close at $2.81 on Tuesday after the company disclosed that it has added Blockchain settlement for cryptocurrency. Future Fintech Group Inc (NASDAQ: FTFT) shares jumped 43.45 percent to close at $6.24 on Tuesday after surging 33.85 percent on Friday. Adomani Inc (NASDAQ: ADOM) shares climbed […]

by

On Thursday GW Pharmaceuticals plc (NASDAQ:GWPH) announced that the recently submitted New Drug Application for Epidiolex was accepted for filing with Priority Review by the U.S. Food and Drug Administration. The drug, a CBD-based treatment, is designed for patients suffering from seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two conditions that stem from childhood […]

by

LONDON and CARLSBAD, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted […]

by

I don’t think I am making a controversial statement here by saying that weed is probably safer than tobacco. Sure, we are still producing minor carcinogens when combusting cannabis—but without all of the gross additives in cigarettes. Aside from the big one (cancer), smoking cigarettes can cause a whole plethora of other problems, one being […]

by

The Top CBD Cannabis Studies of 2017 The past year was important for proponents of medical cannabis. Those seeking to remove cannabis’ Schedule I status are now armed with even more evidence for its medicinal and wellness benefits from a combination of human and rodent studies. From benefits in epilepsy, autism, and beyond, here are […]

by

Gainers Pareteum Corp (NYSE: TEUM) shares jumped 120.87 percent to close at $2.81 on Tuesday after the company disclosed that it has added Blockchain settlement for cryptocurrency. Future Fintech Group Inc (NASDAQ: FTFT) shares jumped 43.45 percent to close at $6.24 on Tuesday after surging 33.85 percent on Friday. Adomani Inc (NASDAQ: ADOM) shares climbed […]

by